Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Myron Chang

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
Journal of Biopharmaceutical Statistics|February 26, 2010
Estimation of multiple response rates in phase II clinical trials with missing observationsMyron Chang
Genetics|October 24, 2003
A general statistical framework for mapping quantitative trait loci in nonmodel systems: issue for characterizing linkage phasesMin Lin, Xiang-Yang Lou, Myron Chang, et al.
Experimental Hematology|June 15, 2007
GM-CSF promotes differentiation of human dendritic cells and T lymphocytes toward a predominantly type 1 proinflammatory responseErika A Eksioglu, Syed S Mahmood, Myron Chang, et al.
Plos One|October 25, 2012
A multi-analyte assay for the non-invasive detection of bladder cancerSteve Goodison, Myron Chang, Yunfeng Dai, et al.
American Journal of Clinical Pathology|April 19, 2007
Expression of anaplastic lymphoma kinase, tyrosine-phosphorylated STAT3, and associated factors in pediatric anaplastic large cell lymphoma: A report from the children's oncology groupMichel R Nasr, Joseph H Laver, Myron Chang, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|August 22, 2013
Attitudes and knowledge of primary care physicians regarding prostate cancer screeningKelly Johnson, Myron Chang, Yilun Sun, et al.
Clinical Medicine Insights. Oncology|December 15, 2010
Combination of IFN-α/Gm-CSF as a Maintenance Therapy for Multiple Myeloma Patients After Autologous Stem Cell Transplantation (ASCT): A Prospective Phase II StudyDonya Salmasinia, Myron Chang, John R Wingard, et al.
Plos One|May 26, 2012
CCL18 in a multiplex urine-based assay for the detection of bladder cancerVirginia Urquidi, Jeongsoon Kim, Myron Chang, et al.
Urology|March 6, 2012
Vascular endothelial growth factor, carbonic anhydrase 9, and angiogenin as urinary biomarkers for bladder cancer detectionVirginia Urquidi, Steve Goodison, Jeongsoon Kim, et al.
The Journal of Urology|October 24, 2012
Diagnostic potential of urinary α1-antitrypsin and apolipoprotein E in the detection of bladder cancerVirginia Urquidi, Steve Goodison, Shanti Ross, et al.
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Journal of Biopharmaceutical Statistics|February 26, 2010
Estimation of multiple response rates in phase II clinical trials with missing observationsMyron Chang
Genetics|October 24, 2003
A general statistical framework for mapping quantitative trait loci in nonmodel systems: issue for characterizing linkage phasesMin Lin, Xiang-Yang Lou, Myron Chang, et al.
Experimental Hematology|June 15, 2007
GM-CSF promotes differentiation of human dendritic cells and T lymphocytes toward a predominantly type 1 proinflammatory responseErika A Eksioglu, Syed S Mahmood, Myron Chang, et al.
Plos One|October 25, 2012
A multi-analyte assay for the non-invasive detection of bladder cancerSteve Goodison, Myron Chang, Yunfeng Dai, et al.
American Journal of Clinical Pathology|April 19, 2007
Expression of anaplastic lymphoma kinase, tyrosine-phosphorylated STAT3, and associated factors in pediatric anaplastic large cell lymphoma: A report from the children's oncology groupMichel R Nasr, Joseph H Laver, Myron Chang, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|August 22, 2013
Attitudes and knowledge of primary care physicians regarding prostate cancer screeningKelly Johnson, Myron Chang, Yilun Sun, et al.
Clinical Medicine Insights. Oncology|December 15, 2010
Combination of IFN-α/Gm-CSF as a Maintenance Therapy for Multiple Myeloma Patients After Autologous Stem Cell Transplantation (ASCT): A Prospective Phase II StudyDonya Salmasinia, Myron Chang, John R Wingard, et al.
Plos One|May 26, 2012
CCL18 in a multiplex urine-based assay for the detection of bladder cancerVirginia Urquidi, Jeongsoon Kim, Myron Chang, et al.
Urology|March 6, 2012
Vascular endothelial growth factor, carbonic anhydrase 9, and angiogenin as urinary biomarkers for bladder cancer detectionVirginia Urquidi, Steve Goodison, Jeongsoon Kim, et al.
The Journal of Urology|October 24, 2012
Diagnostic potential of urinary α1-antitrypsin and apolipoprotein E in the detection of bladder cancerVirginia Urquidi, Steve Goodison, Shanti Ross, et al.
Pageof 7